Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

156
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

GlaxoSmithKline And University Of Nottingham Establish Research Center

04/26/2012 | 05:46am US/Eastern

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Latest news on GLAXOSMITHKLINE PLC
1d ago GLAXOSMITHKLINE : introduces Incruse Ellipta in UK for COPD patients
1d ago GLAXOSMITHKLINE : Assigned Patent
1d ago Regus forecasts capex below estimates, eases fears over debt
2d ago GLAXOSMITHKLINE : Project HOPE and the North Carolina GlaxoSmithKline Foundation..
3d ago Company focus: glaxosmithkline (focus)
4d ago Sanofi shares sink as diabetes sales slow, CEO pressured
4d ago GLAXOSMITHKLINE : *kepler cheuvreux raises glaxosmithkline price target to 1540 ..
4d ago GLAXOSMITHKLINE : China's legal renaissance sounds death knell for Guanxi
4d ago Novartis results top forecasts as new products gain momentum
5d ago GLAXOSMITHKLINE : Publication of Supplementary Prospectus
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF